Company news
Evolus, Inc. Common Stock news in 2022
Evolus, Inc. Common Stock's news releases, calls and decks from 2022, newest first.
Evolus Extends Term of Credit Facility with Pharmakon Advisors
December 7, 2022
Evolus Reports Third Quarter 2022 Results and Provides Business Update
November 7, 2022
Evolus to Report Third Quarter 2022 Results and Provide Business Update
October 24, 2022
Evolus Broadens Its International Presence with Nuceiva® Launch in Great Britain
October 3, 2022
Evolus Concludes Certain Royalty Payments; Financial Profile Improves Significantly Starting in the Fourth Quarter of 2022
September 20, 2022
Evolus Announces Inducement Grants for New Chief Financial Officer
September 5, 2022
Evolus Appoints Sandra Beaver as Chief Financial Officer
August 29, 2022
Evolus Reports Second Quarter 2022 Results and Provides Business Update
August 1, 2022
Evolus to Report Second Quarter 2022 Results and Provide Business Update
July 18, 2022
Evolus Launches New Campaign Inspiring Consumers to “Switch Your Tox and Love Evolus Forever”
July 18, 2022
Evolus Successfully Completes Patient Enrollment in Phase II Clinical Study Evaluating “Extra-Strength” Dose of Jeuveau®
July 11, 2022
Evolus Celebrates Third Anniversary of the Launch of Jeuveau® in the United States
May 17, 2022
Evolus Reports First Quarter 2022 Results and Provides Business Update
May 9, 2022
Evolus to Report First Quarter 2022 Results and Provide Business Update
April 25, 2022
Evolus Announces First Patient Enrolled in Phase II Clinical Study Evaluating “Extra-Strength” Dose of Jeuveau®
March 30, 2022
Evolus Reports Fourth Quarter and Full-Year 2021 Results and Provides Business Update
March 2, 2022
Evolus Announces Retirement of Chief Financial Officer Lauren Silvernail
March 2, 2022
Evolus Names Christos Monovoukas Senior Vice President of Corporate Development
February 28, 2022
Evolus to Report Fourth Quarter and Year End 2021 Results and Provide Business Update
February 16, 2022
Evolus Receives Acceptance of Submission in Australia, a Pivotal Step in Approval Process for Nuceiva®
February 7, 2022
Evolus Announces Preliminary Unaudited Fourth Quarter and Full-Year 2021 Net Revenue and Provides 2022 Guidance
January 25, 2022
Evolus Expands Board of Directors With Appointment of Digital and Beauty Innovator Brady Stewart
January 4, 2022
Calls in 2022
- Evolus, Inc. Common Stock (NASDAQ:EOLS) Q3 2022 Earnings Call
Nov 8, 2022
Transcript - Evolus, Inc. Common Stock (NASDAQ:EOLS) Q2 2022 Earnings Call
Aug 2, 2022
Transcript - Evolus, Inc. Common Stock (NASDAQ:EOLS) Q1 2022 Earnings Call
May 10, 2022
Transcript - Evolus, Inc. Common Stock (NASDAQ:EOLS) Q4 2021 Earnings Call
Mar 3, 2022
Transcript